title: Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Otto-von-Guericke-University, Leipziger Strasse 44, D-39120 Magdeburg, Germany. Eike.Wrenger@medizin.unimagdeburg.de
authors.forename: Eike
authors.initials: E
authors.lastname: Wrenger
authors.forename: Regina
authors.initials: R
authors.lastname: Müller
authors.forename: Michael
authors.initials: M
authors.lastname: Moesenthin
authors.forename: Tobias
authors.initials: T
authors.lastname: Welte
authors.forename: Jürgen C
authors.initials: JC
authors.lastname: Frölich
authors.forename: Klaus H
authors.initials: KH
authors.lastname: Neumann
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004232:Diuretics / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D013148:Spironolactone